Hrt Financial LP Meridian Bioscience Inc Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$31.15 - $33.39 $1.35 Million - $1.44 Million	43,260 New	43,260 $1.44 Million
Q2 2022 Aug 12, 2022	BUY	$23.75 - $31.69 $249,850 - $333,378	10,520 Added 95.68%	21,515 $654,000
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $14,598 - $19,693	731 Added 7.12%	10,995 $285,000
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $170,619 - $211,172	-9,772 Reduced 48.77%	10,264 $209,000
Q3 2021 Nov 15, 2021	BUY	$17.35 - $22.5 $347,624 - $450,810	20,036 New	20,036 $385,000
Q4 2019 Feb 14, 2020	SELL	$7.9 - $10.14 $114,984 - $147,587	-14,555 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$9.17 - $12.01 $133,469 - $174,805	14,555 New	14,555 $138,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.